Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Scientists Discover Remarkable Editing System For Protein Production

Findings Could Help Identify Causes For Neurological and Other Diseases

Even small mistakes made by cells during protein production can have profound disease effects, but the processes cells use to correct mistakes have been challenging to decipher. Recent work by scientists at The Scripps Research Institute, however, has uncovered two surprising new methods for such editing.

The work, published in the January 3, 2008 issue of the journal Nature, and led by Professor Paul Schimmel of the Skaggs Institute for Chemical Biology at Scripps Research, could help identify underlying causes of a range of diseases and, in time, even ways to correct the errors.

Producing proteins is an essential but complicated process involving a number of components. Messenger RNA within cells act as the instructions for protein synthesis. Ribosomes are cellular structures that read these instructions and follow their directions to bind with bits of transfer RNA carrying the amino acids needed for a given protein chain. In most cases, a single unique form of transfer RNA binds only to a single amino acid, and a specific enzyme called a synthetase is responsible for joining the two.

In very rare cases—typically a fraction of a percent—transfer RNA binds with the wrong amino acid. If this error, or mistranslation, is not corrected, that mistranslated amino acid is ultimately incorporated into a protein. Past research by the Schimmel team and others has shown that as little as one wrong amino acid can have profound consequences for health.

"Even such a tiny defect can overwhelm a cell's ability to deal with misfolded proteins, ultimately causing specific neurological problems," says Scripps Research molecular biologist Kirk Beebe, first author of the new paper with Marissa Mock.

Quality Control

The prevailing thinking among researchers in the field has been that the portions of synthetases that recognize and bind transfer RNA and appropriate amino acids are so accurate that little editing is required. What little editing does occur was thought tied to the same checkpoints within the enzymes that perform recognition and binding.

But the current study suggests a new perspective is needed, at least for one widely studied enzyme, a synthetase found in everything from bacteria to humans that binds the amino acid alanine.

The Schimmel team's research revealed that a completely distinct segment of the enzyme acts as a second checkpoint responsible for identifying mistranslations and removing any amino acid besides alanine that might attach to the alanine transfer RNA. Remarkably, this second zone within the enzyme focuses its activity on the very same two nucleotides in the genetic code of the transfer RNA used by the first checkpoint, a guanine and uracil pair referred to as G3•U70.

"The part that is astonishing is that the information that each of these checkpoints is looking for is embedded in the same transfer RNA molecule," says Schimmel, "There's no precedent for this that we're aware of."

The researchers were able to show that this editor checkpoint, even when separated from the rest of the enzyme, was able to efficiently cleave mistranslated amino acids from the alanine transfer RNA. Further experiments revealed that when the G3•U70 pair was transferred to a different type of transfer RNA, the editing unit still removed a non-alanine amino acid, showing clearly that the pair is the trigger for the activity.

Mystery Solved?

The research also led to a surprising find regarding segments of genome-encoded fragments common in cells and sometimes referred to as freestanding domains, whose functions have been debated for many years. The team found that certain freestanding domains with a genetic sequence very similar to the second checkpoint in the alanine synthetase can independently remove mistranslated amino acids in test tube experiments. This suggests that the fragments may act as yet another checkpoint to ensure that proteins are properly synthesized. The activity by the freestanding domain, called AlaXp, also targets the G3•U70 pair.

Whether AlaXp actually edits within cells is not certain, and how they could perform such a function is also not yet clear. "That's still a question to be resolved," says Beebe, "But our work presents a great possibility for how things are likely to occur." The group has already begun new experiments to study AlaXp activity in mouse cells.

"The results of the study were a complete surprise to us," says Schimmel.

Beebe and Schimmel agree that the apparent triple redundancy the team discovered for preventing mistranslation highlights the importance of accurate protein synthesis. It is unlikely such a robustly redundant system would have evolved, they say, if this were not the case.

The work's impact should go beyond adding to the limited understanding of how cells avoid errors during protein synthesis. "We do think there are probably powerful connections to disease," says Schimmel.

Schimmel's and other groups have already shown clear connections between individual and cumulative errors in translation and a variety of problems tied to aging, such as neurodegenerative conditions. Now the Schimmel team has begun collaborative work with a number of other research groups to identify in synthetases telltale genetic mutations referred to as small nucleotide polymorphisms that can lead to mistranslation. Identifying such errors could reveal the underlying causes of diseases currently not understood and possibly identify potential paths for treatment.

In addition to Beebe, Mock, and Schimmel, Eve Merriman was an author on the new Nature paper, entitled "Distinct domains of tRNA synthetase recognize the same base pair." All authors are from The Scripps Research Institute.

The study was funded by the National Institutes of Health, the Skaggs Foundation, and the National Foundation for Cancer Research.

About The Scripps Research Institute

The Scripps Research Institute is one of the world's largest independent, non-profit biomedical research organizations, at the forefront of basic biomedical science that seeks to comprehend the most fundamental processes of life. Scripps Research is internationally recognized for its discoveries in immunology, genetics, molecular and cellular biology, chemistry, neurosciences, autoimmune, cardiovascular, and infectious diseases, cancer biology, and synthetic vaccine development. Established in its current configuration in 1961, it employs approximately 3,000 scientists, postdoctoral fellows, scientific and other technicians, doctoral degree graduate students, and administrative and technical support personnel. Scripps Research is headquartered in La Jolla, California. It also includes Scripps Florida, whose researchers focus on basic biomedical science, drug discovery, and technology development. Currently operating from temporary facilities in Jupiter, Scripps Florida will move to its permanent campus in 2009.

Keith McKeown | EurekAlert!
Further information:

Further reports about: RNA alanine amino amino acids checkpoint enzyme mistranslation synthetase

More articles from Life Sciences:

nachricht Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München

nachricht Second research flight into zero gravity
21.10.2016 | Universität Zürich

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Resolving the mystery of preeclampsia

21.10.2016 | Health and Medicine

Stanford researchers create new special-purpose computer that may someday save us billions

21.10.2016 | Information Technology

From ancient fossils to future cars

21.10.2016 | Materials Sciences

More VideoLinks >>>